Cargando…

Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran

OBJECTIVE: Multi and extensively drug-resistant (MDR and XDR), Pseudomonas aeruginosa (P. aeruginosa) and Acinetobacter baumannii (A. baumannii) are two main causative agents of nosocomial infections leading to increased morbidity and mortality. We aim to study the prevalence of MDR and XDR-A. bauma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirzaei, Bahman, Bazgir, Zahra Norouzi, Goli, Hamid Reza, Iranpour, Fatemeh, Mohammadi, Fatemeh, Babaei, Ryhaneh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418330/ https://www.ncbi.nlm.nih.gov/pubmed/32778154 http://dx.doi.org/10.1186/s13104-020-05224-w

Ejemplares similares

Distribution and Molecular Characterization of Resistance Gene Cassettes Containing Class 1 Integrons in Multi-Drug Resistant (MDR) Clinical Isolates of Pseudomonas aeruginosa
por: Ahmadian, Leila, et al.
Publicado: (2020)

Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
por: Mohammed, Mostafa A., et al.
Publicado: (2020)

Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa
por: Kothari, Ashish, et al.
Publicado: (2023)

Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1
por: Luna, Brian M., et al.
Publicado: (2017)

Risk Factors and Drug Resistance of the MDR Acinetobacter Baumannii in Pneumonia Patients in ICU
por: Ren, Jichen, et al.
Publicado: (2019)

An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
por: Marr, Candace M., et al.
Publicado: (2020)

Profiling of Potential Antibacterial Compounds of Lactic Acid Bacteria against Extremely Drug Resistant (XDR) Acinetobacter baumannii
por: Yap, Phui-Chyng, et al.
Publicado: (2021)

Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced Acinetobacter baumannii
por: Quraini, Munawr AL, et al.
Publicado: (2023)

223. Clinical Characteristics and Outcomes of Acinetobacter baumannii XDR and Pseudomonas aeruginosa XDR in a Tertiary Referral Medical Center in Mexico
por: Ojeda Yuren, Alicia Sarahi, et al.
Publicado: (2023)

CLSI based antibiogram profile and the detection of MDR and XDR strains of Acinetobacter baumannii isolated from urine samples
por: Girija AS, Smiline, et al.
Publicado: (2019)

In vivo bactericidal effect of colistin–linezolid combination in a murine model of MDR and XDR Acinetobacter baumannii pneumonia
por: Ma, Xiao-Lin, et al.
Publicado: (2020)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia – A case report
por: Mohd, Rozita, et al.
Publicado: (2018)

MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017)

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
por: Hameed, H. M. Adnan, et al.
Publicado: (2018)

Role of aminoglycoside-modifying enzymes and 16S rRNA methylase (ArmA) in resistance of Acinetobacter baumannii clinical isolates against aminoglycosides
por: Jouybari, Maryam Asadi, et al.
Publicado: (2021)

Extensive drug resistant (XDR) Acinetobacter baumannii parappendicular-related infection in a hydrocephalus patient with ventriculoperitoneal shunt: a case report
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2020)

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii
por: Kumar, Sunil, et al.
Publicado: (2021)

Classification of Mycobacterium tuberculosis DR, MDR,XDR Isolates and Identification of Signature MutationPattern of Drug Resistance
por: Prasanna, Akshatha, et al.
Publicado: (2019)

Polymyxin Resistance Among XDR ST1 Carbapenem-Resistant Acinetobacter baumannii Clone Expanding in a Teaching Hospital
por: Carrasco, Letícia Dias de Melo, et al.
Publicado: (2021)

Frequency of Multi-Drug Resistance and Molecular Characteristics of Resistance to Colistin in Acinetobacter baumannii Collected from Patients in Intensive Care Units with Ventilator-Associated Pneumonia
por: Babaei, Samaneh, et al.
Publicado: (2021)

Treatment of Extensively Drug-Resistant (XDR) Acinetobacter in US Veterans’ Affairs (VA) Medical Centers
por: Fitzpatrick, Margaret, et al.
Publicado: (2021)

An ionophore breaks the multi-drug-resistance of Acinetobacter baumannii
por: De Oliveira, David M.P., et al.
Publicado: (2022)

Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs
por: Meschiari, Marianna, et al.
Publicado: (2021)

A Nutrient-limited Screen Unmasks Rifabutin Hyperactivity for XDR Acinetobacter baumannii
por: Luna, B., et al.
Publicado: (2020)

In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
por: Lee, Hyukmin, et al.
Publicado: (2016)

Colistin Resistance in Acinetobacter baumannii MDR-ZJ06 Revealed by a Multiomics Approach
por: Hua, Xiaoting, et al.
Publicado: (2017)

Plasmid-Mediated Fluoroquinolone Resistance in Pseudomonas aeruginosa and Acinetobacter baumannii
por: Venkataramana, Geetha P., et al.
Publicado: (2022)

Emerging Trends of Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Salmonella Typhi in a Tertiary Care Hospital of Lahore, Pakistan
por: Zakir, Muhammad, et al.
Publicado: (2021)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of Pseudomonas aeruginosa in the North of Iran
por: Ahmadian, Leila, et al.
Publicado: (2021)

Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections
por: Seleem, Noura M., et al.
Publicado: (2020)

Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii
por: Temocin, Fatih, et al.
Publicado: (2015)

Genomic and proteomic characterization of multi-drug resistant Acinetobacter baumannii
por: Marshall, Dana, et al.
Publicado: (2013)

Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis
por: Agyeman, Akosua Adom, et al.
Publicado: (2016)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania
por: Kumburu, Happiness H, et al.
Publicado: (2019)

Mutation of CarO participates in drug resistance in imipenem‐resistant Acinetobacter baumannii
por: Zhu, Li‐Jing, et al.
Publicado: (2019)

Extensively drug-resistant Acinetobacter baumannii: role of conjugative plasmids in transferring resistance
por: Ababneh, Qutaiba, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nfaa72vsgsbrkso3ejljcfqu0k